Search
for

    Research 1 of 5

    1. Deferasirox, an oral iron chelator, prevents hepatocarcinogenesis and adverse effects of sorafenib Journal of clinical biochemistry and nutrition · 2016 · 12 citations
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →